Keyphrases
Bone Resorption
100%
Glucagon-like
100%
Healthy Postmenopausal Women
100%
Bone Formation
100%
Postmenopausal Women
25%
Day 14
25%
Procollagen Type 1 N-terminal Propeptide (P1NP)
25%
Tachyphylaxis
12%
Saline Control
12%
2-dose
12%
Repeated Dosing
12%
Serum Concentration
12%
Osteocalcin
12%
Serum Osteocalcin
12%
Serious Adverse Reaction
12%
Double-blind Placebo-controlled Trial
12%
Subcutaneous Injection
12%
Urine Concentration
12%
C-terminal Telopeptide
12%
Bone Turnover Markers
12%
Collagen Type I
12%
Dose Effect
12%
Medicine and Dentistry
Osteolysis
100%
Ossification
100%
Postmenopause
100%
Glucagon Like Peptide 2
100%
Procollagen
25%
Osteocalcin
25%
Amino Terminal Sequence
25%
Tachyphylaxis
12%
C-Terminal Telopeptide
12%
Subcutaneous Injection
12%
Bone Turnover
12%
Collagen Type 1
12%
Table Salt
12%
Adverse Event
12%
Placebo
12%
Kidney Concentrating Capacity
12%
Immunology and Microbiology
Postmenopause
100%
Glucagon-Like Peptide
100%
Ossification
100%
Osteolysis
100%
Amino Terminal Sequence
25%
Tachyphylaxis
12%
Kidney Concentrating Capacity
12%
Carboxy Terminal Sequence
12%
Blood Level
12%
Bone Turnover
12%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 2
100%
Osteocalcin
25%
Procollagen
25%
Subcutaneous Injection
12%
Placebo
12%
Table Salt
12%
Collagen Type 1
12%
Tachyphylaxis
12%
Telopeptide
12%
Adverse Event
12%